quinuclidines has been researched along with Colitis Gravis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blomster, LV; Cygankiewicz, AI; Fichna, J; Jacenik, D; Krajewska, WM; Mikkelsen, JD; Piechota-Polańczyk, A; Salaga, M; Zielińska, M | 1 |
| Baird, AW; Goldhill, J; Moriarty, D; O'Donoghue, DP; Selve, N | 1 |
2 other study(ies) available for quinuclidines and Colitis Gravis
| Article | Year |
|---|---|
Encenicline, an α7 Nicotinic Acetylcholine Receptor Partial Agonist, Reduces Immune Cell Infiltration in the Colon and Improves Experimental Colitis in Mice.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Colitis, Ulcerative; Colon; Dextran Sulfate; Flow Cytometry; Forkhead Transcription Factors; Hexamethonium; Interleukin-17; Male; Mice; Mice, Inbred BALB C; Nicotinic Agonists; Nicotinic Antagonists; Peroxidase; Quinuclidines; T-Lymphocytes; Thiophenes; Trinitrobenzenesulfonic Acid | 2016 |
Human colonic anti-secretory activity of the potent NK(1) antagonist, SR140333: assessment of potential anti-diarrhoeal activity in food allergy and inflammatory bowel disease.
Topics: Animals; Antidiarrheals; Capsaicin; Colitis, Ulcerative; Colon; Crohn Disease; Epithelial Cells; Food Hypersensitivity; Guinea Pigs; Humans; Immunoglobulin E; Inflammatory Bowel Diseases; Male; Mast Cells; Neurokinin A; Neurokinin B; Neurokinin-1 Receptor Antagonists; Piperidines; Quinuclidines; Rats; Receptors, Neurokinin-1; Species Specificity; Substance P; Tachykinins | 2001 |